Literature DB >> 26132604

Fatal Neuroleptic Malignant Syndrome Associated With Quetiapine.

Ami Schattner1, Ella Kitroser, Joel D Cohen.   

Abstract

Acute psychosis developed in an elderly patient with Parkinson disease and she was admitted and treated with quetiapine (Seroquel). One day later, high fever unexplained by infection appeared associated with restlessness, confusion, convulsion, leukocytosis, and extreme serum creatine kinase levels. She died of neuroleptic malignant syndrome (NMS) despite intensive treatment. Quetiapine is an atypical neuroleptic agent, rarely associated with NMS in the absence of other contributing drugs. Our case strongly establishes quetiapine-induced NMS (Naranjo scale 6) and is also unique in the abrupt onset and severe refractory course. The steep increase in the prescription of quetiapine worldwide mandates better recognition of this severe adverse reaction, which is fortunately rare, to allow immediate drug withdrawal and appropriate treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26132604     DOI: 10.1097/MJT.0000000000000274

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  6 in total

1.  Vasoplegic Shock Treated with Methylene Blue Complicated by Severe Serotonin Syndrome.

Authors:  Betty S Chan; Therese Becker; Angela L Chiew; Ahmed M Abdalla; Tom A Robertson; Xin Liu; Michael S Roberts; Nicholas A Buckley
Journal:  J Med Toxicol       Date:  2017-11-13

2.  Delusions in Parkinson's Disease: A Systematic Review of Published Cases.

Authors:  Nicola Warren; Cullen O'Gorman; Zena Hume; Steve Kisely; Dan Siskind
Journal:  Neuropsychol Rev       Date:  2018-08-02       Impact factor: 7.444

Review 3.  Neuroleptic malignant syndrome: an easily overlooked neurologic emergency.

Authors:  Ramadhan Oruch; Ian F Pryme; Bernt A Engelsen; Anders Lund
Journal:  Neuropsychiatr Dis Treat       Date:  2017-01-16       Impact factor: 2.570

4.  Neuroleptic malignant syndrome in a patient with moderate intellectual disability treated with olanzapine: A case report.

Authors:  Francesco Piacenza; Suet Kee Ong; Patrick O'Brien; Maurice Clancy
Journal:  Clin Case Rep       Date:  2021-03-15

Review 5.  Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition.

Authors:  Raquel N Taddei; Seyda Cankaya; Sandeep Dhaliwal; K Ray Chaudhuri
Journal:  Parkinsons Dis       Date:  2017-09-12

6.  Forced Diuresis and Expedient Blood Pressure Control in the Management of Quetiapine Induced Neuroleptic Malignant Syndrome: A Case Report.

Authors:  Neville Aquilina; Vincent Bugeja
Journal:  Open Access Maced J Med Sci       Date:  2018-06-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.